Studierne viste en forskel på 15% mellem de behandlede grupper (61% for Visudyne- behandlede mod 46% af de placebo- behandlede patienter, p < 0, 001, ITT analyse).
The studies showed a difference of 15% between treatment groups (61% for Visudyne-treated patients compared to 46% placebo-treated patients, p < 0.001, ITT analysis).